Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Spine Fracture Institute is a U.S.-based specialty spine and pain care organization focused on minimally invasive interventional treatments for vertebral compression fractures, back pain, and other spine-related disorders. Publicly available descriptions consistently associate the organization with Dr. Douglas P. Beall and with clinical operations in the Oklahoma City/Edmond, Oklahoma area. The institute appears to function as a care delivery and interventional spine practice rather than a drug-development biotech or pharma company. Its work is described in connection with interventional radiology, pain management, osteoporotic fracture care, disc disease treatment, and related clinical research and education. Based on available evidence, it is best characterized as a commercial healthcare services entity in the musculoskeletal and spine space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Spine Fracture Institute.